Genetically Engineered Models Have Advantages over Xenografts for Preclinical Studies

作者: Oren J. Becher , Eric C. Holland

DOI: 10.1158/0008-5472.CAN-05-3827

关键词:

摘要: Mouse models of human cancer are valuable tools for research. Although xenografts and genetically engineered (GEMs) possess limitations as well advantages, each system plays a significant role in preclinical testing. Tumor easy to use, relatively inexpensive, reproducible. The main drawback is that the genetics histology tumors frequently not representative respective tumor and, thus far, these have been predictive therapeutic success one would like. By contrast, GEMs histologically accurate but disadvantages heterogeneity with regard frequency, latency, growth. These reminiscent variable behavior actual tumors. Recently, shortcomings partly overcome development anatomic molecular vivo imaging techniques such magnetic resonance bioluminescence imaging. new technologies will hopefully support use trials help determine if more predicative than responses.

参考文章(20)
Michael P. Rosenberg, Donna Bortner, Why transgenic and knockout animal models should be used (for drug efficacy studies in cancer) Cancer and Metastasis Reviews. ,vol. 17, pp. 295- 299 ,(1998) , 10.1023/A:1006196614142
Anne-Karina Perl, Ulf Dahl, Petra Wilgenbus, Harold Cremer, Henrik Semb, Gerhard Christofori, Reduced expression of neural cell adhesion molecule induces metastatic dissemination of pancreatic beta tumor cells. Nature Medicine. ,vol. 5, pp. 286- 291 ,(1999) , 10.1038/6502
Lene Uhrbom, Eric C. Holland, Modeling Gliomagenesis with Somatic Cell Gene Transfer using Retroviral Vectors Journal of Neuro-oncology. ,vol. 53, pp. 297- 305 ,(2001) , 10.1023/A:1012208314436
Gabriele Bergers, Rolf Brekken, Gerald McMahon, Thiennu H. Vu, Takeshi Itoh, Kazuhiko Tamaki, Kazuhiko Tanzawa, Philip Thorpe, Shigeyoshi Itohara, Zena Werb, Douglas Hanahan, Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis Nature Cell Biology. ,vol. 2, pp. 737- 744 ,(2000) , 10.1038/35036374
J. M. Adams, A. W. Harris, C. A. Pinkert, L. M. Corcoran, W. S. Alexander, S. Cory, R. D. Palmiter, R. L. Brinster, The c- myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice Nature. ,vol. 318, pp. 533- 538 ,(1985) , 10.1038/318533A0
Paul Bates, John A.T. Young, Harold E. Varmus, A receptor for subgroup A Rous sarcoma virus is related to the low density lipoprotein receptor Cell. ,vol. 74, pp. 1043- 1051 ,(1993) , 10.1016/0092-8674(93)90726-7
Timothy A. Stewart, Paul K. Pattengale, Philip Leder, Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes Cell. ,vol. 38, pp. 627- 637 ,(1984) , 10.1016/0092-8674(84)90257-5
Jan Cools, Daniel J. DeAngelo, Jason Gotlib, Elizabeth H. Stover, Robert D. Legare, Jorges Cortes, Jeffrey Kutok, Jennifer Clark, Ilene Galinsky, James D. Griffin, Nicholas C.P. Cross, Ayalew Tefferi, James Malone, Rafeul Alam, Stanley L. Schrier, Janet Schmid, Michal Rose, Peter Vandenberghe, Gregor Verhoef, Marc Boogaerts, Iwona Wlodarska, Hagop Kantarjian, Peter Marynen, Steven E. Coutre, Richard Stone, D. Gary Gilliland, A Tyrosine Kinase Created by Fusion of thePDGFRAandFIP1L1Genes as a Therapeutic Target of Imatinib in Idiopathic Hypereosinophilic Syndrome New England Journal of Medicine. ,vol. 348, pp. 1201- 1214 ,(2003) , 10.1056/NEJMOA025217